Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12737-12744

  Chaillon, Antoine ^a,b   Wagner, Gabriel A ^a   Hepler, N Lance ^a   Little, Susan J ^a   Kosakovsky Pond, Sergei L ^a   Caballero, Gemma ^c   Pacold, Mary E ^d   Phung, Pham ^e   Wrin, Terri ^e   Richman, Douglas D ^a,c   Wertheim, Joel O ^a   Smith, Davey M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSERM   (France)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d Life Technologies Corporation   (United States)

^e MONOGRAM BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ENVELOPE GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; MALE; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; SUPERINFECTION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; ANTIBODIES, NEUTRALIZING; BIOLOGICAL EVOLUTION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SUPERINFECTION; YOUNG ADULT;

EID: 84887203517     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02260-13     Document Type: Article

References (38)

1. Ramos A, Hu DJ, Nguyen L, Phan K-O, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, Mastro TD, Folks TM, Subbarao S. 2002. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 76:7444-7452.
2. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE, Perrin L. 2002. A patient with HIV-1 superinfection. N. Engl. J. Med. 347:731-736.
3. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ. 2005. HIV drug resistance acquired through superinfection. AIDS 19:1251-1256.
4. Pacold ME, Pond SLK, Wagner GA, Delport W, Bourque DL, Richman DD, Little SJ, Smith DM. 2012. Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men. AIDS 26:157-165.
5. Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J, Li F, Liu S-L, Rademeyer C, Learn GH, Karim SSA, Williamson C, Corey L, Margolick JB, Mullins JI. 2004. Dual HIV-1 infection associated with rapid disease progression. Lancet 363:619-622.
6. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, Maier EL, Harlow J, Goulder PJ, Brander C, Rosenberg ES, Walker BD. 2002. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420:434-439.
7. Kijak GH, McCutchan FE. 2005. HIV diversity, molecular epidemiology, and the role of recombination. Curr. Infect. Dis. Rep. 7:480-488.
8. Yang C, Li M, Shi Y-P, Winter J, van Eijk AM, Ayisi J, Hu DJ, Steketee R, Nahlen BL, Lal RB. 2004. Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya. AIDS Res. Hum. Retrovir. 20:565-574.
9. Smith DM, Strain MC, Frost SDW, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. 2006. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 355:1-5.
10. Basu D, Kraft CS, Murphy MK, Campbell PJ, Yu T, Hraber PT, Irene C, Pinter A, Chomba E, Mulenga J, Kilembe W, Allen SA, Derdeyn CA, Hunter E. 2012. HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection. Retrovirology 9:76.
11. Pacold M, Smith D, Little S, Cheng PM, Jordan P, Ignacio C, Richman D, Pond SK. 2010. Comparison of methods to detect HIV dual infection. AIDS Res. Hum. Retrovir. 26:1291-1298.
12. Cousins MM, Ou S-S, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD. 2012. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J. Clin. Microbiol. 50:3054-3059.
13. Shibata R, Siemon C, Cho MW, Arthur LO, Nigida SM, Jr, Matthews T, Sawyer LA, Schultz A, Murthy KK, Israel Z, Javadian A, Frost P, Kennedy RC, Lane HC, Martin MA. 1996. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70:4361-4369.
14. Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
15. Richman DD, Wrin T, Little SJ, Petropoulos CJ. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U S. A. 100:4144-4149.
16. Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. 2001. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. U.S.A. 98:13288-13293.
17. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
18. Frost SDW, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman DD. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U.S.A. 102:18514-18519.
19. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK. 2013. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N. Engl. J. Med. 368:218-230.
20. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. 2011. Detection of minority resistance during early HIV-1 infection:natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J. Virol. 85:8359-8367.
21. Smith D, Delport W, Butler D, Little S, Richman D, Pond SK. 2010. Response to comment on "The origins of sexually transmitted HIV among men who have sex with men." Sci. Transl. Med. 2:501r1. doi:10.1126 /scitranslmed.3001473.
22. Delport W, Poon AFY, Frost SDW, Kosakovsky Pond SL. 2010. Datamonkey 2010:a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics 26:2455-2457.
23. Pond SLK, Frost SDW, Muse SV. 2005. HyPhy:hypothesis testing using phylogenies. Bioinformatics 21:676-679.
24. Zagordi O, Klein R, Däumer M, Beerenwinkel N. 2010. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 38:7400-7409.
25. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N. 2011. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics 12:119. doi:10.1186/1471-2105-12-119.
26. Eriksson N, Pachter L, Mitsuya Y, Rhee S-Y, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N. 2008. Viral population estimation using pyrosequencing. PLoS Comput. Biol. 4:e1000074. doi:10 .1371/journal.pcbi.1000074.
27. Beerenwinkel N, Zagordi O. 2011. Ultra-deep sequencing for the analysis of viral populations. Curr. Opin. Virol. 1:413-418.
28. Tamura K, Nei M. 1993. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10:512-526.
29. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5:molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony. Methods Mol. Biol. Evol. 28:2731-2739.
30. Poon AFY, McGovern RA, Mo T, Knapp DJHF, Brenner B, Routy J-P, Wainberg MA, Harrigan PR. 2011. Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial nextgeneration sequencing data. AIDS 25:2019-2026.
31. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping L-H, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 105:7552-7557.
32. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SDW. 2006. GARD:a genetic algorithm for recombination detection. Bioinformatics 22:3096-3098.
33. Katoh K, Asimenos G, Toh H. 2009. Multiple alignment of DNA sequences with MAFFT. Methods Mol. Biol. 537:39-64.
34. Hall TA. 1999. BioEdit:a user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
35. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29:1969-1973.
36. Streeck H, Li B, Poon AFY, Schneidewind A, Gladden AD, Power KA, Daskalakis D, Bazner S, Zuniga R, Brander C, Rosenberg ES, Frost SDW, Altfeld M, Allen TM. 2008. Immune-driven recombination and loss of control after HIV superinfection. J. Exp. Med. 205:1789-1796.
37. Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J. 2008. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. J. Virol. 82:12094-12103.
38. Zagordi O, Geyrhofer L, Roth V, Beerenwinkel N. 2010. Deep sequencing of a genetically heterogeneous sample:local haplotype reconstruction and read error correction. J. Comput. Biol. J. Comput. Mol. Cell. Biol. 17:417-428.